July 15, 2026 · Form 4 insider transaction
Goncalves Joana sold 3,803 shares of Oruka Therapeutics, Inc. at $86.68 per share, a transaction worth $329.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.21 to $87.04, inclusive.